Print this page
-
Targeted Genomic Analysis of Human Cancers.
Protocol: 001209Principal Investigator:
- Shridar Ganesan MD, PhD (Rutgers University)
Applicable Disease Sites: Any Site -
Palbociclib and Binimetinib in RAS-Mutant Cancers
Protocol: 172403Principal Investigator:
- Shridar Ganesan MD, PhD (Rutgers University)
Applicable Disease Sites: Any Site -
Phase 2 Study of Paclitaxel + Ipatasertib in Taxane-Refractory Participants with AKT-Altered Advanced Non-Breast Solid Tumors.
Protocol: 172404Principal Investigator:
- Shridar Ganesan MD, PhD (Rutgers University)
Applicable Disease Sites: Any Site -
Molecular Analysis for Combination Therapy Choice (ComboMATCH)
Protocol: 172301Principal Investigator:
- Shridar Ganesan MD, PhD (Rutgers University)
Applicable Disease Sites: Any Site -
Evolution and Clinical Impact of Clonal Hematopoiesis of Indeterminate Potential in Breast Tumor Microenvironment.
Protocol: 001839Principal Investigator:
- Shridar Ganesan MD, PhD (Rutgers University)
Applicable Disease Sites: Breast -
Endogenous Retrovirus Expression, Chromatin Abnormalities and Response to Immune Checkpoint Blockade in Clear Cell Renal Cell Cancer.
Protocol: 081909Principal Investigator:
- Shridar Ganesan MD, PhD (Rutgers University)
Applicable Disease Sites: Other Urinary